GSK Cancer Vaccine Fails in Melanoma Late-Stage Trial
Sept. 6, 2013
An experimental cancer vaccine from GlaxoSmithKline failed to help melanoma patients in a closely watched late-stage clinical trial, dealing a blow to the high-risk, high-reward project. Read the full story
